BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 29323190)

  • 1. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.
    Daly C; Qian X; Castanaro C; Pasnikowski E; Jiang X; Thomson BR; Quaggin SE; Papadopoulos N; Wei Y; Rudge JS; Thurston G; Yancopoulos GD; Davis S
    Sci Rep; 2018 Jan; 8(1):505. PubMed ID: 29323190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
    Hansen TM; Singh H; Tahir TA; Brindle NP
    Cell Signal; 2010 Mar; 22(3):527-32. PubMed ID: 19922791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO
    J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.
    De A; Maulik D; Lankachandra K; Mundy DC; Ye SQ; Gerkovich MM
    J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3421-8. PubMed ID: 26752164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2.
    Kim KT; Choi HH; Steinmetz MO; Maco B; Kammerer RA; Ahn SY; Kim HZ; Lee GM; Koh GY
    J Biol Chem; 2005 May; 280(20):20126-31. PubMed ID: 15769741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
    Wu C; Kim PY; Swystun LL; Liaw PC; Weitz JI
    J Thromb Haemost; 2016 Feb; 14(2):366-74. PubMed ID: 26663133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap.
    Bate N; Lodge J; Brindle NPJ
    J Biol Chem; 2021 Aug; 297(2):100888. PubMed ID: 34153320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT; Boffa MB
    J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis.
    Kim HZ; Jung K; Kim HM; Cheng Y; Koh GY
    Biochim Biophys Acta; 2009 May; 1793(5):772-80. PubMed ID: 19339208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial destabilization by angiopoietin-2 via integrin β1 activation.
    Hakanpaa L; Sipila T; Leppanen VM; Gautam P; Nurmi H; Jacquemet G; Eklund L; Ivaska J; Alitalo K; Saharinen P
    Nat Commun; 2015 Jan; 6():5962. PubMed ID: 25635707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
    Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
    J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
    van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
    J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.
    Saito M; Watanabe J; Fujisawa T; Kamata Y; Nishimura Y; Arai T; Miyamoto T; Obokata A; Kuramoto H
    Eur J Gynaecol Oncol; 2006; 27(2):129-34. PubMed ID: 16620053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
    Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
    Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling.
    Ikezoe T; Yang J; Nishioka C; Honda G; Furihata M; Yokoyama A
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2259-70. PubMed ID: 22796578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietins are expressed in the normal rat pituitary gland.
    Nag S; Nourhaghighi N; Venugopalan R; Asa SL; Stewart DJ
    Endocr Pathol; 2005; 16(1):67-73. PubMed ID: 16000849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
    Pietilä R; Nätynki M; Tammela T; Kangas J; Pulkki KH; Limaye N; Vikkula M; Koh GY; Saharinen P; Alitalo K; Eklund L
    J Cell Sci; 2012 May; 125(Pt 9):2212-23. PubMed ID: 22357955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L; Nesheim M; Morser J; Tracy PB
    J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Human Neutrophil Extracellular Traps Contributes to Angiopoietin-Mediated In Vitro Proinflammatory and Proangiogenic Activities.
    Lavoie SS; Dumas E; Vulesevic B; Neagoe PE; White M; Sirois MG
    J Immunol; 2018 Jun; 200(11):3801-3813. PubMed ID: 29686052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.